Journal articles
- Research
- Our research
- For patients and consumers
- Clinical Trials
- Pre-approval planning
- Ethics approval
- Research governance
- Post-approval submissions
- Supporting research
- Contact Us
Metro North is committed to providing a platform to acknowledge and promote research excellence within our health service. Below is a list of research publications from across our hospitals and services.
- High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD) 21 December 2025CONCLUSION: Vitamin D supplementation did not prevent PC progression, although reduced prevalence of CBMN markers may indicate a benefit of vitamin D supplementation.Visalini Nair-Shalliker
- Intestinal Ultrasound for Inflammatory Bowel Disease: The Sound at the End of the Tunnel? 20 December 2025No abstractR Gilmore
- Current Antibiotic Options for the Treatment of Infections with AmpC-Producing Enterobacterales 20 December 2025AmpC β-lactamases, found in certain Enterobacterales, confer resistance to third-generation cephalosporins, some β-lactam/β-lactamase inhibitor combinations, and cephamycins. They may be chromosomal or plasmid-mediated. Generally, third-generation cephalosporins are avoided in the treatment of high-risk AmpC producers, with cefepime or carbapenems being preferred for severe infections. Non-β-lactam options (fluoroquinolones, trimethoprim-sulfamethoxazole, and aminoglycosides) remain viable...Jinghao Nicholas Ngiam
- Rapid Diagnostic Strategies for Antibiotic-Resistant Bacteria Causing Bloodstream Infection 20 December 2025Novel technologies for the diagnosis of bloodstream infection are emerging, with the potential to improve patient care. Antimicrobial stewardship programs have proven essential to embed such tests into clinical practice and thus support early appropriate antimicrobial therapy. Yet, the best implementation strategies for these tests are still unknown and likely dependent on the specific scenarios, […]Anna Maria Peri
- Pelvic lymph node dissection in prostate cancer, still no level 1 evidence of oncological benefit. Time to consider surveillance of negative pelvic lymph nodes on PSMA PET scan staging 20 December 2025No abstractJ W Yaxley
- Incidence of late-onset hyperlactatemia and association with clinical outcomes in intensive care patients 19 December 2025CONCLUSION: The limited data regarding late-onset hyperlactatemia make it difficult to draw significant conclusions regarding the relationship to clinical outcomes. However, the few available studies suggest that it is a common finding and highlight the need for further research to assess the underlying aetiologies and association with clinical outcomes.Aashish Kumar
- Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116] 19 December 2025No abstractSheldon E Litwin
- Mobilisation OverViEw in a Quaternary intensive care unit: A cross-sectional descriptive survey 19 December 2025CONCLUSIONS: This study highlights low awareness of EM guidelines and the presence of persistent system-level barriers to EM despite clinicians' positive attitudes and intentions. Findings suggest that stronger guideline dissemination, education, and practical supports are needed to embed EM into routine ICU practice. Future research should focus on implementation strategies and evaluation of safe, context-specific […]Andrew J Neilson
- Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group 19 December 2025We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.Andrew J Vickers
- Humidity-driven ABA depletion determines plant-pathogen competition for leaf water 19 December 2025Bacterial phytopathogens, such as Pseudomonas syringae pv. tomato (Pst) DC3000, induce water-soaked lesions in the leaf apoplast under high humidity, facilitating infection. However, it remains largely unclear how plants regulate their resistance to restrict bacterial infection in response to humidity. Here, we demonstrate that abscisic acid (ABA)-catabolizing ABA 8'-hydroxylase, encoded by CYP707A3, plays a critical […]Shigetaka Yasuda
- The Pandemic REspiratory Virus Epidemiological SurveillaNce Trial - A self-swab surveillance system for respiratory viruses nested within FluTracking 18 December 2025CONCLUSION: Regular self-collected nasal swabs for detecting respiratory viruses in a community setting is feasible in Australia and provides valuable information on asymptomatic infection.Camille Esneau
- Author Correction: Current standard of care for septic shock 18 December 2025No abstractAnthony Delaney
- Clinical Implementation of Urinary Neutrophil Gelatinase-Associated Lipocalin: It's Nuanced 18 December 2025No abstractRobert J Ellis
- Predictors of VV-ECMO weaning safety: longitudinal ventilatory ratio assessment during sweep gas off trials, a retrospective cohort study 17 December 2025CONCLUSIONS: Elevated ventilatory ratio during SGOT was associated with unsafe weaning from VV-ECMO in this retrospective cohort of patients with ARDS. Prospective validation is warranted to inform future weaning practice.Elliott Worku
- Carbon fibre PEEK versus titanium cephalomedullary nails for management of oncological lesions of the femur: a retrospective cohort study 17 December 2025CONCLUSION: Our study demonstrates no difference in the safety and efficacy profile of CF-PEEK nails as compared to titanium alloy nails in the management of oncological lesions of the femur. This needs to be interpreted with caution given the underpowered nature of this study. Furthermore, the current implant cost of CF-PEEK nails is prohibitive. Adequately […]Christian Marx
